DiverSet

ChemBridge Corporation the first truly diverse collection of hand-synthesized chemical compounds for high-throughput screening. ChemBridge Corporation ChemBridge's flagship product for lead generation that was born from the international collaboration between ChemBridge Corporation and Chemical Design Ltd. (UK), a leading developer of software tools for the pharmaceutical industry and a pioneer in 3-D pharmacophore technology.

ChemBridge Corporation a unique set of 10,000 to 50,000 drug-like, hand-synthesized small molecules, rationally pre-selected to form a "universal" library that covers the maximum pharmacophore diversity with the minimum number of compounds. Geared for primary screening against a wide range of biological targets, including those where no structural information is available, DIVERSet can benefit any pharmaceutical, biotech or agrochemical company with an active HTS or lower-throughput screening program.

Choosing DIVERSet can substantially cut drug discovery timescales and costs by reducing the number of compounds tested, while offering a rational strategy to systematically explore molecular diversity space. With its unmatched diversity, quality and variety of HTS-robotics compatible vial and plate formats available, ChemBridge Corporation now considered by industry experts to be the best screening library of hand-synthesized compounds on the market.
There are several cost-effective purchasing options available for DIVERSet designed to accommodate the requirements and budgets of different groups of clients. Collaborative compound access agreements might be considered as well.

<%=company%>, 16981 Via Tazon, Suite G, San Diego, CA 92127. Tel: 858-451-7400 x21; Fax: 858-451-7401